Belum VR - Search Results

1

Dermatological adverse events with taxane chemotherapy.

Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Sibaud V, et al. Among authors: belum vr. Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833. Eur J Dermatol. 2016. PMID: 27550571 Free PMC article. Review.

2

Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Dai J, Belum VR, Wu S, Sibaud V, Lacouture ME. Dai J, et al. Among authors: belum vr. J Am Acad Dermatol. 2017 Nov;77(5):902-910.e2. doi: 10.1016/j.jaad.2017.06.044. Epub 2017 Sep 14. J Am Acad Dermatol. 2017. PMID: 28918974 Free PMC article. Review.

3

Dermatological adverse events from BRAF inhibitors: a growing problem.

Belum VR, Fischer A, Choi JN, Lacouture ME. Belum VR, et al. Curr Oncol Rep. 2013 Jun;15(3):249-59. doi: 10.1007/s11912-013-0308-6. Curr Oncol Rep. 2013. PMID: 23463215 Review.

4

Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.

Belum VR, Washington C, Pratilas CA, Sibaud V, Boralevi F, Lacouture ME. Belum VR, et al. Pediatr Blood Cancer. 2015 May;62(5):798-806. doi: 10.1002/pbc.25429. Epub 2015 Feb 12. Pediatr Blood Cancer. 2015. PMID: 25683226 Free PMC article.

5

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.

Capriotti K, Capriotti JA, Lessin S, Wu S, Goldfarb S, Belum VR, Lacouture ME. Capriotti K, et al. Among authors: belum vr. Br J Dermatol. 2015 Sep;173(3):842-5. doi: 10.1111/bjd.13743. Epub 2015 Jul 29. Br J Dermatol. 2015. PMID: 25704465 Review. No abstract available.

6

Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.

Belum VR, Serna-Tamayo C, Wu S, Lacouture ME. Belum VR, et al. Clin Exp Dermatol. 2016 Jan;41(1):8-15. doi: 10.1111/ced.12694. Epub 2015 May 25. Clin Exp Dermatol. 2016. PMID: 26009777 Free PMC article. Review.

7

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.

Belum VR, Benhuri B, Postow MA, Hellmann MD, Lesokhin AM, Segal NH, Motzer RJ, Wu S, Busam KJ, Wolchok JD, Lacouture ME. Belum VR, et al. Eur J Cancer. 2016 Jun;60:12-25. doi: 10.1016/j.ejca.2016.02.010. Epub 2016 Apr 1. Eur J Cancer. 2016. PMID: 27043866 Free PMC article. Review.

8

Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors.

Zarbo A, Belum VR, Sibaud V, Oudard S, Postow MA, Hsieh JJ, Motzer RJ, Busam KJ, Lacouture ME. Zarbo A, et al. Among authors: belum vr. Br J Dermatol. 2017 Jun;176(6):1649-1652. doi: 10.1111/bjd.15237. Epub 2017 Apr 24. Br J Dermatol. 2017. PMID: 27943234 Free PMC article.

9

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.

Sibaud V, Eid C, Belum VR, Combemale P, Barres B, Lamant L, Mourey L, Gomez-Roca C, Estilo CL, Motzer R, Vigarios E, Lacouture ME. Sibaud V, et al. Among authors: belum vr. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e464-e469. doi: 10.1111/jdv.14284. Epub 2017 May 8. J Eur Acad Dermatol Venereol. 2017. PMID: 28419570 Free PMC article. No abstract available.

10

Differential radiation dermatitis in native skin and an autologous transplanted myocutaneous flap.

Belum VR, Hill A, Matros E, Lacouture ME, Barker CA. Belum VR, et al. JAMA Dermatol. 2014 Dec;150(12):1365-7. doi: 10.1001/jamadermatol.2014.888. JAMA Dermatol. 2014. PMID: 25102826 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page